BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33917805)

  • 1. Increased Levels of Adipocyte and Epidermal Fatty Acid-Binding Proteins in Acute Lymphoblastic Leukemia Survivors.
    Konończuk K; Latoch E; Żelazowska-Rutkowska B; Krawczuk-Rybak M; Muszyńska-Rosłan K
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33917805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity.
    Haider DG; Schindler K; Bohdjalian A; Prager G; Luger A; Wolzt M; Ludvik B
    Diabetes Obes Metab; 2007 Sep; 9(5):761-3. PubMed ID: 17359244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.
    Xu A; Wang Y; Xu JY; Stejskal D; Tam S; Zhang J; Wat NM; Wong WK; Lam KS
    Clin Chem; 2006 Mar; 52(3):405-13. PubMed ID: 16423904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults.
    Hong J; Gu W; Zhang Y; Yan Q; Dai M; Shi J; Zhai Y; Wang W; Li X; Ning G
    Atherosclerosis; 2011 Jul; 217(1):194-200. PubMed ID: 21492859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Frequency of Metabolic Syndrome and Serum Osteopontin Levels in Survivors of Childhood Acute Lymphoblastic Leukemia.
    Özdemir ZC; Düzenli Kar Y; Demiral M; Sırmagül B; Bör Ö; Kırel B
    J Adolesc Young Adult Oncol; 2018 Aug; 7(4):480-487. PubMed ID: 29641359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia.
    Konończuk K; Muszyńska-Rosłan K; Konstantynowicz-Nowicka K; Krawczuk-Rybak M; Chabowski A; Latoch E
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Markers of metabolic syndrome and peptides regulating metabolism in survivors of childhood acute lymphoblastic leukemia].
    Skoczeń S; Tomasik P; Balwierz W; Surmiak M; Sztefko K; Galicka-Latała D
    Przegl Lek; 2011; 68(9):592-6. PubMed ID: 22335007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
    Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
    Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.
    Corripio R; Gónzalez-Clemente JM; Pérez-Sánchez J; Näf S; Gallart L; Nosàs R; Vendrell J; Caixàs A
    Eur J Endocrinol; 2010 Dec; 163(6):887-93. PubMed ID: 20870707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating adipocyte fatty acid-binding protein, juvenile obesity, and metabolic syndrome.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Mierzchala M; Hotowy K; Czapinska E; Kustrzeba-Wojcicka I; Gamian A; Noczynska A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):921-8. PubMed ID: 22308843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipocyte fatty acid-binding protein in obese children before and after weight loss.
    Reinehr T; Stoffel-Wagner B; Roth CL
    Metabolism; 2007 Dec; 56(12):1735-41. PubMed ID: 17998029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children.
    Yun KE; Kim SM; Choi KM; Park HS
    Metabolism; 2009 Jun; 58(6):798-802. PubMed ID: 19368945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss.
    Stejskal D; Karpisek M; Bronsky J
    J Clin Lab Anal; 2008; 22(5):380-2. PubMed ID: 18803274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is there dependence between the level of adipocyte fatty acid-binding protein and calcium score in asymptomatic relatives of patients with cardiovascular diseases?].
    Sovová E; Vrbková J; Stejskal D; Kaletová M; Kamínek M; Metelková I; Sova M; Benušová I; Doupalová P
    Vnitr Lek; 2013 Jan; 59(1):31-6. PubMed ID: 23428000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis.
    Yeung DC; Wang Y; Xu A; Cheung SC; Wat NM; Fong DY; Fong CH; Chau MT; Sham PC; Lam KS
    Eur Heart J; 2008 Sep; 29(17):2156-63. PubMed ID: 18603624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of metabolic syndrome parameters in pediatric acute lymphoblastic leukemia survivors.
    Kartal Ö; Gürsel O
    Indian J Cancer; 2023; 60(3):325-330. PubMed ID: 36861687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia.
    Karpisek M; Stejskal D; Kotolova H; Kollar P; Janoutova G; Ochmanova R; Cizek L; Horakova D; Yahia RB; Lichnovska R; Janout V
    Eur J Clin Invest; 2007 Aug; 37(8):637-42. PubMed ID: 17635574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.